Frontlight ResearchEarly access
Trial site
Moscow
- 1running trial
- 2closed trials
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- Asthma1 trial
- Chronic spontaneous urticaria1 trial
- Multiple sclerosis1 trial
- Phase
- Phase 22 trials
- Phase 41 trial
- Status
- Completed2 trials
- Active, not recruiting1 trial
- Lead sponsor
- Sanofi3 trials
Running trials
Active, not recruiting
Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple Sclerosis
Closed trials
Completed
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026